Literature DB >> 15193438

The genetics of renal oncocytosis: a possible model for neoplastic progression.

Tahseen Al-Saleem1, Paul Cairns, Essel A Dulaimi, Madelyn Feder, Joseph R Testa, Robert G Uzzo.   

Abstract

Renal oncocytosis is a rare condition characterized by the presence of numerous oncocytomas and oncocytic changes in the renal tubules. Other than oncocytomas associated with the Birt-Hogg-Dube (BDH) syndrome, the genetics of oncocytosis is not known. Whether oncocytomas and oncocytosis are similar to BDH syndrome, in which the tumors diploid (as most oncocytomas are), or show chromosomal losses may be significant regarding the observation that in oncocytosis, there frequently is morphological evidence of progression to chromophobe carcinoma. Here we report on the case of a 69-year old male who underwent a staged procedure of partial nephrectomy on the left side and right radical nephrectomy for multiple renal tumors. The tumors were studied by routine hematoxylin and eosin morphology, immunohistochemistry, cytogenetics, and loss of heterozygosity analysis. Both kidneys had numerous oncocytic neoplasms morphologically progressing from oncocytomas to hybrid tumors with chromophobe carcinoma. Genetic studies demonstrated progression from normal cytogenetics to chromosomal losses similar to those in some oncocytomas and in chromophobe carcinomas. The genetics of this apparently nonfamilial oncocytoma differs from that of BDH syndrome and is characterized by losses involving chromosomes 1, 14, 21, and Y. To our knowledge, this is the first report of the genetic and cytogenetic findings in oncocytosis not related to BDH syndrome and may suggest a possible model of progression from oncocytoma to chromophobe renal cell carcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 15193438     DOI: 10.1016/j.cancergencyto.2003.10.001

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

Review 1.  Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm?

Authors:  Th Van der Kwast; B Perez-Ordoñez
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

2.  Renal oncocytosis: management and clinical outcomes.

Authors:  Ari Adamy; William T Lowrance; David S Yee; Kian Tai Chong; Melanie Bernstein; Satish K Tickoo; Jonathan A Coleman; Paul Russo
Journal:  J Urol       Date:  2011-01-15       Impact factor: 7.450

3.  Contrast enhanced ultrasound of renal masses.

Authors:  Andre Ignee; Bernd Straub; Gudrun Schuessler; Christoph Frank Dietrich
Journal:  World J Radiol       Date:  2010-01-28

4.  Dysplastic ("in-situ") Lesions in multofocal renal oncocytomas (oncocytosis).

Authors:  Jiaoti Huang; Peng Lee; Yoshiki Mikami; Jonathan Melamed
Journal:  Int J Clin Exp Pathol       Date:  2009-06-18

5.  Genome-wide promoter methylome of small renal masses.

Authors:  Ilsiya Ibragimova; Michael J Slifker; Marie E Maradeo; Gowrishankar Banumathy; Essel Dulaimi; Robert G Uzzo; Paul Cairns
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

Review 6.  Modern Pathologic Diagnosis of Renal Oncocytoma.

Authors:  Sara E Wobker; Sean R Williamson
Journal:  J Kidney Cancer VHL       Date:  2017-10-09

Review 7.  Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.

Authors:  Francesco Trevisani; Matteo Floris; Roberto Minnei; Alessandra Cinque
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

8.  Renal adenomas: pathological differential diagnosis with malignant tumors.

Authors:  F Algaba
Journal:  Adv Urol       Date:  2008-10-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.